1 completed, 1 terminated, 1 withdrawn. 2 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 1, Withdrawn 1 |
| Phase 2 | 1 | Terminated 1 |
Follow Fasiglifam: new trials by email Literature Review of Fasiglifam trials Research Report on Fasiglifam
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Fasiglifam in Type 2 Diabetic Subjects With Chronic Kidney Disease Stage 4 or 5 on Hemodialysis Fasiglifam, Placebo, Antihyperglycemic therapy - Type 2 Diabetes Mellitus, Chronic Kidney Disease | Phase 3 | Withdrawn | Takeda | 2013-12-01 | 2014-01-27 | |
| Fasiglifam 25 mg BID vs 50 mg QD Fasiglifam, Placebo to fasiglifam - Type 2 Diabetes Mellitus | Phase 2 | Terminated | Takeda | 10 | 2013-10-01 | 2016-10-07 |
| Comparison of TAK-875 (Fasiglifam) With Placebo in Participants With Type 2 Diabetes Placebo, Fasiglifam - Diabetes Mellitus, Type 2 | Phase 3 | Completed | Takeda | 421 | 2011-11-01 | 2016-04-05 |
Diabetes Mellitus, Type 2 (3) · Renal Insufficiency, Chronic (1)
Takeda (3)
Bulgaria (3) · Slovakia (3) · Ukraine (3) · United States (3) · Hungary (2) · Poland (2) · Argentina (1) · Guatemala (1) · Mexico (1) · Romania (1) · South Africa (1) · Taiwan (1)